Actions of the NLRP3 and NLRC4 inflammasomes overlap in bone resorption

Area of Science:

• Immunology
• Bone Biology
• Inflammation Research

Background:

• Innate immune receptors, particularly NOD-like receptor (NLR) family inflammasomes, are implicated in tissue damage.
• The specific roles of NLRP3 and NLRC4 inflammasomes in bone metabolism and homeostasis remain largely unexplored.

Purpose of the Study:

• To investigate the interplay between NLRP3 and NLRC4 inflammasomes in regulating bone homeostasis and inflammatory bone loss.
• To elucidate the contribution of these inflammasomes to osteoclast differentiation and bone mass accrual.

Main Methods:

• In vitro studies assessing osteoclast differentiation in NLRP3 or NLRC4 deficient cells.
• In vivo studies using wild-type (WT) and knockout (Nlrp3/Nlrc4 deficient) mice to analyze bone mass and response to LPS-induced osteolysis.
• Measurement of serum IL-1β levels in different mouse models.

Main Results:

• Loss of NLRP3 or NLRC4 inflammasome attenuated in vitro osteoclast differentiation.
• Mice lacking NLRP3, or to a lesser extent NLRC4, exhibited higher baseline bone mass and protection against inflammatory osteolysis.
• Bone mass in Nlrp3-deficient mice was normalized when NLRC4 was also absent, indicating a compensatory mechanism.
• Lower serum IL-1β levels correlated with increased bone mass in mutant mice.

Conclusions:

• NLRP3 and NLRC4 inflammasomes play significant roles in regulating bone homeostasis and inflammatory bone loss.
• While individual inflammasome deficiencies alter bone mass, the combined absence of NLRP3 and NLRC4 leads to normal bone homeostasis, suggesting functional redundancy or complex regulatory interactions.
• These findings highlight the intricate involvement of inflammasomes in skeletal health and disease.